31 May

4Q17 Earnings Preview: What to Expect from Casey’s

WRITTEN BY Sonya Bells

Series snapshot

Iowa-based Casey’s General Stores (CASY) is slated to report its fourth-quarter 2017 and fiscal 2017 results on Tuesday, June 6, 2017.

Wall Street has predicted a 28.0% YoY (year-over-year) fall in the retailer’s earnings to $0.86 per share. Total sales for 4Q17 are projected to rise 18.8% YoY to $1.9 billion. The company fell short of Wall Street’s earnings and revenue estimates in the three previous quarters of the current fiscal year.

4Q17 Earnings Preview: What to Expect from Casey’s

About Casey’s

Casey’s General Stores and its subsidiaries operate 1,950 convenience stores in the United States. The company sells fuel and a wide range of grocery items and prepared foods in 15 Midwestern states.

Casey’s makes up 1.0% of the portfolio holdings of the SPDR S&P Retail ETF (XRT).


Casey’s has touched its 52-week high and is currently trading at a one-year forward PE (price-to-earnings) ratio of 24.7x. That compares to its three-year average PE ratio of 21.0x.

The company continues to be cheaper than CST Brands (CST), which is valued at 29.0x. Murphy USA (MUSA), however, trades at a discount and is valued at 16.6x for the next 12 months of earnings.

What’s this series all about?

This series is a preview of Casey’s 4Q17 results. We’ll look at the company’s year-to-date financial performance, its key revenue drivers, and its stock market performance and current valuation. We’ll also see what Wall Street analysts are recommending for the company.

Latest articles

In Q3, billionaire investor Leon Cooperman's top five holdings were Fiserv, Alphabet, United Continental, Chimera Investment, and Cigna.

In 2018, 3,503 metric tons of gold were produced globally, 1.8% higher than in 2017. Let's look at the world's top gold-producing countries.

TJX Companies (TJX) reported better-than-expected earnings results for the third quarter of fiscal 2020, which ended on November 2.

Despite Canada's legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.

On November 11, the NHS (National Health Service) approved two cannabis-based medicines, Epidyolex and Sativex, for use in the United Kingdom.

Roku (ROKU) stock tanked more than 5% on Tuesday during market hours. The company said it will issue nearly 1 million common shares today.